Rimonabant is now also available in the United Arab Emirates for treatment of abdominally obese people with cardiometabolic risk factors, according to a June announcement by producer Sanofi-Aventis.This is the first announced launch of Acomplia in the Middle East. The …

Successful obesity treatments for weight loss reduction and maintenance must be started and continued under the care of a physician and/or a nutritionist. A weight-loss program may include:

* Exercise
* A low-fat, high-complex …